Search Results - "Oh, Chung Ryul"

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib by Oh, Chung Ryul, Kong, Sun-Young, Im, Hyeon-Su, Kim, Hwa Jung, Kim, Min Kyeong, Yoon, Kyong-Ah, Cho, Eun-Hae, Jang, Ja-Hyun, Lee, Junnam, Kang, Jihoon, Park, Sook Ryun, Ryoo, Baek-Yeol

“…Although sorafenib is the global standard first-line systemic treatment for unresectable hepatocellular carcinoma (HCC), it does not have reliable predictive…”
Get full text

Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer by Oh, Chung Ryul, Kim, Eo Jin, Chae, Heejung, Park, Young Soo, Ryu, Min-Hee, Kim, Hyung-Don, Kang, Yoon-Koo

“…Background We examined the impact of mismatch repair (MMR) status on efficacy of first-line fluoropyrimidine plus platinum (FP) chemotherapy in patients with…”
Get full text

Gastrocolocutaneous Fistula: An Unusual Case of Gastrostomy Tube Malfunction with Diarrhea by Lee, Junghwan, Kim, Jinyoung, Kim, Ha Il, Oh, Chung Ryul, Choi, Sungim, Noh, Soomin, Na, Hee Kyong, Jung, Hwoon-Yong

“…A gastrocolocutaneous fistula is a rare complication of percutaneous endoscopic gastrostomy (PEG). We report a case of a gastrocolocutaneous fistula presenting…”
Get full text

Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum chemotherapy for metastatic, recurrent, or locally advanced unresectable gastric cancer by Oh, Chung Ryul, Kim, Eo Jin, Chae, Heejung, Park, Young Soo, Ryu, Min-Hee, Kim, Hyung-Don, Kang, Yoon-Koo

“…461 Background: In localized gastric cancer (GC), deficient mismatch repair (dMMR) tumors reportedly have a favorable prognosis. However, a potentially…”
Get full text

Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability‐high/mismatch repair‐deficient or POLE‐mutated metastatic or unresectable colorectal cancer by Oh, Chung Ryul, Kim, Jeong Eun, Hong, Yong Sang, Kim, Sun Young, Ahn, Joong Bae, Baek, Ji Yeon, Lee, Myung‐Ah, Kang, Myoung Joo, Cho, Sang Hee, Beom, Seung‐Hoon, Kim, Tae Won

“…The aim of our study is to evaluate the clinical efficacy of durvalumab in patients with microsatellite instability‐high/mismatch repair‐deficient (MSI‐H/dMMR)…”
Get full text

Preoperative chemoradiotherapy with capecitabine with or without temozolomide in patients with locally advanced rectal cancer: A prospective, randomized phase 2 study stratified by MGMT (O 6 -methylguanine DNA methyltransferase) status: KCSG-CO17-02 by Oh, Chung Ryul, Jeong, Jae Ho, Lee, Ji Sung, Kim, Jeong Eun, Kim, Sun Young, Kim, Tae Won, Choi, Jene, Kim, Jihun, Park, In Ja, Lim, Seok-Byung, Park, Jin-hong, Kim, Jong Hoon, Choi, Moon Ki, Cha, Yongjun, Baek, Ji Yeon, Beom, Seung-Hoon, Hong, Yong Sang

“…3605 Background: We aimed to evaluate the clinical efficacy of adding temozolomide (TMZ) to preoperative capecitabine (CAP)-based chemoradiotherapy (CRT) in…”
Get full text

Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer by Oh, Chung Ryul, Kim, Hyung-Don, Ryu, Yeon-Mi, Lee, Seonmin, Kim, Danbee, Lee, DA Sol, Jeong, Jae Ho, Chang, Heung-Moon, Ryoo, Baek-Yeol, Kim, Kyu-Pyo, Kim, Miyeon, Kim, Sang-Yeob, Yoo, Changhoon

“…This study evaluated the clinical implications of epithelial-mesenchymal transition (EMT) markers and peritumoral immune cell infiltration in patients with…”
Get more information

Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study by Oh, Chung Ryul, Jeong, Hyehyun, Kim, Wanlim, Lee, Jong-Seok, Song, Si Yeol, Song, Joon Seon, Cho, Kyung-Ja, Chung, Hye Won, Lee, Min Hee, Hong, Jung Yong, Lee, Jeeyun, Kim, Jeong Eun, Ahn, Jin-Hee

“…Background The real-world evidence about the efficacy of cytotoxic chemotherapy in desmoid tumors is still limited. We investigated the efficacy of…”
Get full text

Abstract 4600: Biomarker analysis in circulating cell-free DNA in patients treated with sorafenib for advanced hepatocellular carcinoma by Park, Sook Ryun, Oh, Chung Ryul, Kong, Sun-Young, Kim, Min Kyeong, Yoon, Kyong-Ah, Cho, Eun-Hae, Lee, Junnam, Kang, Jihoon, Ryoo, Baek-Yeol

“…Abstract Purpose: We evaluated the potential role of Vascular Endothelial Growth Factor-A (VEGFA) amplification and genome-wide copy number variations (CNVs)…”
Get full text

Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery by Oh, Chung Ryul, Kim, Jeong Eun, Kang, Jihoon, Kim, Sun Young, Kim, Kyu-pyo, Hong, Yong Sang, Lim, Seok-Byung, Yu, Chang Sik, Kim, Jin Cheon, Kim, Jihun, Jang, Se Jin, Kim, Tae Won

“…We investigated whether the microsatellite instability status affects the survival outcomes in patients with stage II/III rectal cancer. A total of 1103…”
Get full text

Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion by Yoo, Changhoon, Oh, Chung Ryul, Kim, Seung-Tae, Bae, Woo Kyun, Choi, Hye-Jin, Oh, Do-Youn, Lee, Myung-Ah, Ryoo, Baek-Yeol

“…Neuroendocrine tumors (NETs) are a group of malignancies arising from neuroendocrine cells and frequently originate in the gastrointestinal tract and pancreas…”
Get full text

Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study by Oh, Chung Ryul, Hong, Jung Yong, Kim, Jee Hung, Lee, Ji Sung, Kim, Hyo Song, Kim, Tae Won, Ahn, Jin-Hee, Kim, Jeong Eun

“…Background Pazopanib is the only tyrosine kinase inhibitor approved for the treatment of patients with advanced soft tissue sarcoma (STS) who have received…”
Get full text